• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT.

作者信息

Gran Charlotte, Wang Junfeng, Nahi Hareth, Koster Linda, Gahrton Gösta, Einsele Herman, Niittyvoupio Riitta, Edinger Matthias, Beelen Dietrich, Ciceri Fabio, Bornhäuser Martin, Finke Jürgen, de Wreede Liesbeth C, Ljungman Per, Mielke Stephan, Tischer Johanna, Garderet Laurent, Schönland Stefan, Yakoub-Agha Ibrahim, Kröger Nicolaus

机构信息

Karolinska University Hospital, Stockholm, Sweden.

EBMT Statistical Unit, Leiden, The Netherlands.

出版信息

Br J Haematol. 2020 Jun;189(5):e213-e217. doi: 10.1111/bjh.16642. Epub 2020 Apr 16.

DOI:10.1111/bjh.16642
PMID:32301111
Abstract
摘要

相似文献

1
Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT.用于多发性骨髓瘤异基因移植的曲奥舒凡预处理——一线造血干细胞移植中总生存期的改善——欧洲血液与骨髓移植协会慢性恶性肿瘤工作组的一项大型回顾性研究
Br J Haematol. 2020 Jun;189(5):e213-e217. doi: 10.1111/bjh.16642. Epub 2020 Apr 16.
2
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT.采用基于三氟柳的异基因造血细胞移植与其他减强度或清髓性预处理方案治疗骨髓增生异常综合征患者：来自 EBMT 慢性恶性肿瘤工作组的报告。
Br J Haematol. 2021 Nov;195(3):417-428. doi: 10.1111/bjh.17817. Epub 2021 Sep 12.
3
Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.基于苏消安预处理方案治疗急性髓系白血病患者的长期预后：欧洲血液与骨髓移植学会急性白血病工作组的报告
Cancer. 2017 Jul 15;123(14):2671-2679. doi: 10.1002/cncr.30646. Epub 2017 Mar 22.
4
Acute toxicity and outcome among pediatric allogeneic hematopoietic transplant patients conditioned with treosulfan-based regimens.接受基于苏消安方案预处理的儿科异基因造血移植患者的急性毒性和结局
Pediatr Hematol Oncol. 2020 Aug;37(5):355-364. doi: 10.1080/08880018.2020.1738604. Epub 2020 Mar 13.
5
Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients.曲奥舒凡/氟达拉滨作为高危患者异基因造血干细胞移植预处理方案
Am J Hematol. 2008 Sep;83(9):717-20. doi: 10.1002/ajh.21240.
6
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.使用白消安为基础的清髓性预处理方案及外周血干细胞进行单倍体相合造血干细胞移植后环磷酰胺和西罗莫司的应用
Biol Blood Marrow Transplant. 2015 Aug;21(8):1506-14. doi: 10.1016/j.bbmt.2015.04.025. Epub 2015 May 19.
7
Treosulfan-Based Conditioning Regimen in Haematopoietic Stem Cell Transplantation with TCRαβ/CD19 Depletion in Nijmegen Breakage Syndrome.在范可尼贫血症中，采用 TCRαβ/CD19 耗竭的造血干细胞移植中，基于三氧化二砷的预处理方案。
J Clin Immunol. 2020 Aug;40(6):861-871. doi: 10.1007/s10875-020-00811-9. Epub 2020 Jun 30.
8
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia.噻替哌、白消安和氟达拉滨与白消安和环磷酰胺相比，作为急性髓系白血病患者接受来自匹配的同胞供体和无关供体的异基因干细胞移植的预处理方案。
Am J Hematol. 2018 Oct;93(10):1211-1219. doi: 10.1002/ajh.25225. Epub 2018 Aug 15.
9
Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.体内T细胞清除对采用氟达拉滨-静脉白消安清髓方案预处理的首次完全缓解期急性髓系白血病患者进行HLA全相合异基因干细胞移植的影响：欧洲血液与骨髓移植协会急性白血病工作组报告
J Hematol Oncol. 2017 Jan 24;10(1):31. doi: 10.1186/s13045-016-0389-4.
10
Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?抗胸腺细胞球蛋白在白消安/氟达拉滨预处理方案用于匹配相关供者造血干细胞移植中是否有一席之地？
Korean J Intern Med. 2016 Jul;31(4):750-61. doi: 10.3904/kjim.2015.234. Epub 2016 Mar 28.

引用本文的文献

1
Haploidentical Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Extramedullary Multiple Myeloma: A Conditioning Regimen Combining Selinexor and Helical Tomotherapy-A Case Report and Literature Review.单倍体相合造血干细胞移植治疗复发/难治性髓外多发性骨髓瘤：一种塞利尼索与螺旋断层放疗联合预处理方案——病例报告及文献综述
J Blood Med. 2025 Apr 2;16:177-185. doi: 10.2147/JBM.S495256. eCollection 2025.
2
Historical Perspective of Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma.多发性骨髓瘤异基因造血干细胞移植的历史回顾
Acta Haematol. 2025;148(3):315-329. doi: 10.1159/000542704. Epub 2024 Nov 25.
3
Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years.
异基因干细胞移植治疗多发性骨髓瘤的疗效与生存结果：近10年的荟萃分析
Front Oncol. 2024 Jul 31;14:1341631. doi: 10.3389/fonc.2024.1341631. eCollection 2024.
4
Allogeneic stem cell transplantation in multiple myeloma: is there still a place?异基因干细胞移植在多发性骨髓瘤中的应用：还有立足之地吗？
Front Oncol. 2024 Jun 4;14:1402106. doi: 10.3389/fonc.2024.1402106. eCollection 2024.
5
Treosulfan Exposure Predicts Thalassemia-Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation.硼替佐米治疗多发性骨髓瘤的疗效及安全性评价
Clin Pharmacol Ther. 2024 Jan;115(1):116-125. doi: 10.1002/cpt.3078. Epub 2023 Nov 7.
6
Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma.曲奥舒凡与美法仑大剂量化疗治疗多发性骨髓瘤的疗效与安全性
Cancers (Basel). 2023 May 10;15(10):2699. doi: 10.3390/cancers15102699.
7
Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma.三氧化二砷联合氟达拉滨与 TEAM 方案作为自体造血干细胞移植前预处理方案治疗 B 细胞非霍奇金淋巴瘤的疗效比较。
Bone Marrow Transplant. 2022 Jul;57(7):1164-1170. doi: 10.1038/s41409-022-01701-x. Epub 2022 May 10.
8
Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma.异基因干细胞移植在多发性骨髓瘤中的当前作用
Oncol Ther. 2022 Jun;10(1):105-122. doi: 10.1007/s40487-022-00195-3. Epub 2022 Apr 4.
9
Allogeneic Stem Cell Transplantation in Multiple Myeloma.多发性骨髓瘤中的异基因干细胞移植
Cancers (Basel). 2021 Dec 23;14(1):55. doi: 10.3390/cancers14010055.
10
A comparison of the efficacy and safety of ixazomib and lenalidomide combined with dexamethasone in the treatment of multiple myeloma.伊沙佐米与来那度胺联合地塞米松治疗多发性骨髓瘤的疗效和安全性比较
Am J Transl Res. 2021 May 15;13(5):5248-5255. eCollection 2021.